Subscribe To
Here's why skillz stock shot up today
Analysts love the company's ongoing revenue growth. But what about profits?...
February 9, 2022, 4:01 pm
Here's why skillz stock shot up today
Analysts love the company's ongoing revenue growth. But what about profits?...
February 9, 2022, 4:01 pm
Here's why skillz stock shot up today
Analysts love the company's ongoing revenue growth. But what about profits?...
February 9, 2022, 4:01 pm
Microsoft appeals to regulators with new app policies so they don't kill its $69 billion activision deal
New commitments could help Microsoft look like less of a target in Washington after the company revealed its plan to buy game publisher Activision Bli...
February 9, 2022, 11:32 am
Microsoft appeals to regulators with new app policies so they don't kill its $69 billion activision deal
New commitments could help Microsoft look like less of a target in Washington after the company revealed its plan to buy game publisher Activision Bli...
February 9, 2022, 11:32 am
Microsoft appeals to regulators with new app policies so they don't kill its $69 billion activision deal
New commitments could help Microsoft look like less of a target in Washington after the company revealed its plan to buy game publisher Activision Bli...
February 9, 2022, 11:32 am
Skillz (sklz) stock: why the price jumped
The stock price of Skillz Inc (NYSE: SKLZ) increased by 5.15% in the most recent trading session. This is why it happened....
February 9, 2022, 3:43 am
Skillz (sklz) stock: why the price jumped
The stock price of Skillz Inc (NYSE: SKLZ) increased by 5.15% in the most recent trading session. This is why it happened....
February 9, 2022, 3:43 am
Skillz (sklz) stock: why the price jumped
The stock price of Skillz Inc (NYSE: SKLZ) increased by 5.15% in the most recent trading session. This is why it happened....
February 9, 2022, 3:43 am
2 natural-killer cell therapy oncology companies investors should watch
Natural-killer cell therapy is one of the most recent paradigms in cancer treatment, and two prominent companies working on this new technology are Fa...
February 8, 2022, 3:03 pm
2 natural-killer cell therapy oncology companies investors should watch
Natural-killer cell therapy is one of the most recent paradigms in cancer treatment, and two prominent companies working on this new technology are Fa...
February 8, 2022, 3:03 pm
2 natural-killer cell therapy oncology companies investors should watch
Natural-killer cell therapy is one of the most recent paradigms in cancer treatment, and two prominent companies working on this new technology are Fa...
February 8, 2022, 3:03 pm
International expansion could help skillz stock turn a corner
With Skillz expanding internationally and shoring up its balance sheet, the worst may finally be over for SKLZ stock. The post International Expansion...
February 8, 2022, 6:00 am
International expansion could help skillz stock turn a corner
With Skillz expanding internationally and shoring up its balance sheet, the worst may finally be over for SKLZ stock. The post International Expansion...
February 8, 2022, 6:00 am
International expansion could help skillz stock turn a corner
With Skillz expanding internationally and shoring up its balance sheet, the worst may finally be over for SKLZ stock. The post International Expansion...
February 8, 2022, 6:00 am
Skillz announces date for fourth quarter 2021 results
SAN FRANCISCO--(BUSINESS WIRE)--Skillz Inc. (NYSE: SKLZ) (“Skillz”), the leading mobile games platform bringing fair and fun competition to player...
February 7, 2022, 4:30 pm
Skillz announces date for fourth quarter 2021 results
SAN FRANCISCO--(BUSINESS WIRE)--Skillz Inc. (NYSE: SKLZ) (“Skillz”), the leading mobile games platform bringing fair and fun competition to player...
February 7, 2022, 4:30 pm
Skillz announces date for fourth quarter 2021 results
SAN FRANCISCO--(BUSINESS WIRE)--Skillz Inc. (NYSE: SKLZ) (“Skillz”), the leading mobile games platform bringing fair and fun competition to player...
February 7, 2022, 4:30 pm
Astrazeneca covid jab criticism cost 'hundreds of thousands' of lives claims professor
An Oxford University professor has reignited the row over AstraZeneca PLC (LSE:AZN)'s covid vaccine by claiming the criticism the jab received might h...
February 7, 2022, 9:07 am
Astrazeneca covid jab criticism cost 'hundreds of thousands' of lives claims professor
An Oxford University professor has reignited the row over AstraZeneca PLC (LSE:AZN)'s covid vaccine by claiming the criticism the jab received might h...
February 7, 2022, 9:07 am